Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: Comment on the article by Beukelman et al

Arthritis Care and Research

Volumn 63, Issue 9, 2011, Pages 1354-1355

  Huppertz, Hans Iko ^a  

^a Childrens' Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; METHOTREXATE; RITUXIMAB; TOCILIZUMAB;

CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; LONG TERM CARE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYNOVITIS; SYSTEMIC THERAPY; TREATMENT INDICATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; HUMANS; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY;

EID: 80052301561     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20521     Document Type: Letter

References (2)

1. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011; 63: 465-82.
2. Rosenberg AM, Oen KG,. Polyarthritis. In:, Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology. 6th ed. Philadelphia: Saunders; 2011. p. 249-61.